Maybe I can give you some information, at least about the effectiveness of the MedEffect website.
We know that since it was implemented in 2005, as a result of therapeutics access strategy resourcing, there were over two million page views and web traffic of approximately 860,000 visits to that website in 2006. So we know from that statistic alone that there is significant interest in that website.
We also note from a survey we did in 2006, a public consultation on the MedEffect website and the online use of it, that there was significant awareness and trust in it, and that Canadians had faith in that vehicle to communicate.
I think part of our problem is that.... I don't want to say no two Canadians are alike, but obviously people have different preferences as to what site they would like to use in terms of the way it's configured. So probably a one-all solution isn't the best. We recognize, for example, that as Ms. Ballantyne said, the Canadian Medical Association and its daily infoPOEMs.... I am a physician and I get those daily, directly in my e-mail box, and I use them. Those are one method of communicating risk information. Other Canadians may prefer the MedEffect website, while others may prefer the Public Health Agency of Canada or other vehicles. We recognize that.
What I can tell you is that we have consulted with Canadians, and the majority of those consulted did have confidence in the MedEffect website as a reliable source of information.